Close Menu

DOD

Contract Lost

According to Science, the independent Jason advisory group to the US Department of Defense has lost its contract.

More to Do

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

The two-year contract will be used to develop a portable prototype to quickly identify critical infectious pathogens considered threatening to war combatants.

The consortium aims to identify tuberculosis protein targets and corresponding small molecule inhibitors that can be used to develop drugs to shorten therapy duration.

The study aims to explore the "unique benefits and challenges" or incorporating genomic information into the routine care of active duty Air Force members.

The study being conducted under the Genomes2People umbrella will explore how best to introduce genetic information into the routine care of active duty service members. 

Bioinformatics firm Berg is combining multi-omics data from the Department of Defense's Center for Prostate Disease Research in search of biomarkers.

The funding will go toward completing the development of the company's point-of-care platform for distinguishing bacterial from viral infections.

The funding will advance work focused on the discovery of a genomic configuration that correlates to chemotherapy sensitivity.

Pages

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.